Fin Trust Capital Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Fin Trust Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$74.43 - $92.22 $1,042 - $1,291	14 New	14 $1,000
Q2 2022 Jul 26, 2022	SELL	$71.48 - $86.85 $3,574 - $4,342	-50 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $3,586 - $4,573	50 New	50 $4,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $7,551 - $8,479	-100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $7,473 - $9,069	100 New	100 $8,000
Q2 2019 Aug 01, 2019	SELL	$80.35 - $93.9 $1,124 - $1,314	-14 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$80.14 - $106.07 $1,121 - $1,484	14 New	14 $1,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.